Literature DB >> 7199403

Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries.

A Pasternac, J Noble, Y Streulens, R Elie, C Henschke, M G Bourassa.   

Abstract

To clarify the pathogenesis of chest pain in patients with cardiomyopathies, we compared coronary blood flow and other indicators of ischemia at rest and during pacing-induced tachycardia in nine patients with cardiomyopathy (four hypertrophic and five congestive) and in five control subjects. Coronary blood flow was reduced at rest and during pacing in cardiomyopathy patients compared with controls. In patients with hypertrophic cardiomyopathy, pacing induced chest pain in all, increased ST-segment depression in three patients and increased coronary venous lactate concentration. With pacing, two of five patients with congestive cardiomyopathy had chest discomfort and three had increased ST-segment depression, but coronary venous lactate concentration did not change significantly. In both groups of cardiomyopathies, the ratio of the systolic and diastolic pressure-time indexes tended to decrease more than in controls during pacing. Thus, myocardial perfusion is decreased in patients with cardiomyopathy, both at rest and during pacing. The changes detected during pacing point to subendocardial ischemia as the likely mechanism for angina in hypertrophic and possibly also in congestive cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7199403     DOI: 10.1161/01.cir.65.4.778

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

1.  Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy.

Authors:  J J Crowley; P S Dardas; A A Harcombe; L M Shapiro
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

Review 2.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics.

Authors:  M J Kofflard; M Michels; R Krams; M Kliffen; M L Geleijnse; F J Ten Cate; P W Serruys
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

4.  Angina pectoris and physiological coronarographic findings.

Authors:  Mehmed Kulić; Elnur Tahirović; Zina Lazović
Journal:  Bosn J Basic Med Sci       Date:  2009-08       Impact factor: 3.363

Review 5.  Syndrome X.

Authors:  A H Henderson
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

6.  Coronary artery-left ventricular shunt: an important cause of chest pain in patients with hypertrophic cardiomyopathy.

Authors:  Mareomi Hamada; Akiyoshi Ogimoto; Kiyotaka Ohshima; Shigehiro Miyazaki; Norio Kubota; Shuntarto Ikeda; Yuji Shigematsu
Journal:  Heart Vessels       Date:  2018-05-02       Impact factor: 2.037

Review 7.  Natural history of hypertrophic cardiomyopathy.

Authors:  P Spirito; P Bellone
Journal:  Br Heart J       Date:  1994-12

8.  Left ventricular dysfunction in patients with angina pectoris and normal coronary angiograms.

Authors:  P M Schofield; N H Brooks; D H Bennett
Journal:  Br Heart J       Date:  1986-10

9.  Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.

Authors:  M Shimizu; N Sugihara; Y Kita; K Shimizu; Y Horita; K Nakajima; J Taki; R Takeda
Journal:  Br Heart J       Date:  1992-02

10.  A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS).

Authors:  Y Okajima; Y Tanabe; M Takayanagi; H Aotsuka
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.